Results 101 to 110 of about 2,092 (196)
Cerebrolysin: spectrum of activity and research data. Part 2
The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease.
N. D. Bukreeva, E. A. Rakityanskaya
doaj
Morphofunctional changes in a rat model of Parkinson's disease - Effects of neurotrophic factors administration [PDF]
255 p.La investigación actual se basa en la búsqueda de estrategias terapéuticas que consigan detener el proceso neurodegenerativo de la enfermedad de Parkinson. Por tanto, la administración de factores neurotróficos puede ser un tratamiento beneficioso.
Requejo Rodríguez, Catalina
core +1 more source
Fariborz Ghaffarpasand,1 Saeed Torabi,2 Ali Rasti,3 Mohammad Hadi Niakan,4 Sara Aghabaklou,5 Fatemeh Pakzad,6 Maryam Sadat Beheshtian,7 Reza Tabrizi8 1Research Center for Neuromodulation and Pain, Shiraz University of Medical Sciences, Shiraz, Iran ...
Ghaffarpasand F +7 more
doaj
Objective: To investigate the effect of cerebrolysin (CBL) on motor impairment, neuroinflammation, oxidative stress, and neurotransmitter profile in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease (PD) in zebrafish ...
Dilpreet Kaur, Shamsher Singh
doaj +1 more source
Cerebrolysin in Neuroleptic Complicatiuns
V. Kontzevov +3 more
openaire +1 more source
Effects of Cerebrolysin and its Significance
Вже декілька десятиріч Церебролізин широко застосовується в клінічній практиці для лікування інсультів, хвороби Альцгеймера та травматичного ушкодження головного мозку. У зв’язку з тим, що препарат інтенсивно досліджується (станом на сьогодні опубліковано більше ніж 170 статей), згадування його назви стало асоціюватися з такими термінами, як ...
openaire +1 more source
Editorial: Pushing the boundaries in acute ischemic stroke treatment. [PDF]
Kallmünzer, Bernd +2 more
core +1 more source
Effect of cerebrolysin in patients with ischemic stroke: A double-blind randomized control study
We investigated the effect of cerebrolysin compared with placebo efficacy in patients with ischemic stroke. A total of 50 patients with ischemic stroke participate in this randomized double-blind placebo-controlled study.
Seyed Ali Mousavi +4 more
doaj
Peptide profiling of internet obtained Cerebrolysin using HPLC-ESI-IT & UHPLC-Q-IM-TOF mass spectrometry [PDF]
Bracke, Nathalie +8 more
core +1 more source
Surgical excision of cerebral glioma and multimodal treatment including Cerebrolysin: a case report. [PDF]
González JDSR, Tapia A.
europepmc +1 more source

